Recurrent group 4 (non-SHH/non-WNT) medulloblastoma

Clinical trials for Recurrent group 4 (non-SHH/non-WNT) medulloblastoma explained in plain language.

Never miss a new study

Get alerted when new Recurrent group 4 (non-SHH/non-WNT) medulloblastoma trials appear

Sign up with your email to follow new studies for Recurrent group 4 (non-SHH/non-WNT) medulloblastoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

Immune cocktail takes on tough brain cancer in kids

Disease control Recruiting now

This early-phase trial is testing whether a combination of immune-based treatments is safe and feasible for children and young adults (ages 4–30) with a recurrent form of medulloblastoma, a type of brain cancer. The treatment includes personalized dendritic cell vaccines, immune …

Matched conditions: RECURRENT GROUP 4 (NON-SHH/NON-WNT) MEDULLOBLASTOMA

Phase 1 • Sponsor: University of Florida • Aim: Disease control

Last updated Aug 09, 2026 00:00 UTC

Recurrent group 4 (non-SHH/non-WNT) medulloblastoma

Get alerted when new Recurrent group 4 (non-SHH/non-WNT) medulloblastoma trials appear

Immune cocktail takes on tough brain cancer in kids